Comparison Between Using Cardiometry and IVC Collapsibility
1 other identifier
observational
60
1 country
1
Brief Summary
Sepsis is a life-threatening condition caused by a dysregulated host response to infection, leading to organ dysfunction. Septic shock, a severe form of sepsis, is characterized by persistent hypotension and cellular/metabolic abnormalities despite adequate fluid resuscitation. It is associated with high mortality rates globally, necessitating timely diagnosis and treatment. Fluid resuscitation and vasopressor use are cornerstones of management, but they must be tailored to the individual to prevent complications such as fluid overload.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2025
CompletedFirst Submitted
Initial submission to the registry
January 30, 2026
CompletedFirst Posted
Study publicly available on registry
February 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2026
CompletedFebruary 13, 2026
May 1, 2025
1 year
January 30, 2026
February 8, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Septic Shock Evaluation
Assessment of the participants which suffering from Septic Shock by using Inferior Vena Cava Collapsibility and Electrical Cardiometry for assisting the Fluid Responsiveness
Two Hours
Study Arms (2)
Electrical Cardiometry Monitoring
Non-invasive assessment of stroke volume and cardiac output using electrical cardiometry at baseline and after fluid challenge.
Inferior Vena Cava Collapsibility Assessment Group
Thirty patients with septic shock will undergo bedside ultrasound assessment of the inferior vena cava to measure the collapsibility index for evaluation of fluid responsiveness. Measurements will be performed as part of routine clinical monitoring without any alteration to standard clinical management.
Interventions
Bedside ultrasound measurement of inferior vena cava diameters during the respiratory cycle to calculate the collapsibility index at baseline and after fluid challenge
Eligibility Criteria
Study protocol approval prior to implementation of the research will be obtained from Faculty of Medicine, Menoufia University Research Ethics Committee. Parents were informed about the study purpose and its consequences, confirming confidentiality of data. A signed informed consent was a pre-requisite for the study. Type of study: Prospective study Site of study: This study will be conducted at the Intensive Care Unit, Faculty of Medicine, Menoufia university Hospital. The study population: The study will include (60) septic Shock patients who admitted to Intensive Care Unit.
You may qualify if:
- Patients Diagnosed with Hypotensive Sepsis: Patients must meet the clinical criteria for sepsis according to the Sepsis-3 definitions, including evidence of infection and hypotension despite adequate fluid resuscitation. Hypotension is defined as systolic blood pressure \<90 mmHg or mean arterial pressure (MAP) \<65 mmHg.
- BMI ≥18.5 and ≤40 kg/m²: Patients will be included regardless of BMI, as long as it falls within the normal to overweight/obese range. Extremes of BMI (e.g., \<18.5 or \>40) may be excluded due to the potential influence on peripheral perfusion measurements.
- American Society of Anesthesiologists (ASA) Physical Status Classification as:
- ASA Score I-III: Patients with an ASA physical status score of I (healthy patients), II (mild systemic disease), or III (severe systemic disease) will be included. Patients with ASA IV or V (those with severe systemic disease that is a constant threat to life) will be excluded due to potential confounding factors.
You may not qualify if:
- \- Cardiac Conditions: Significant valvular heart diseases, such as severe mitral or aortic regurgitation, which can affect hemodynamic assessments.
- Presence of major cardiac arrhythmias, including atrial fibrillation or frequent ectopic beats, as these can interfere with accurate measurement of fluid responsiveness.
- \- Renal Considerations: Patients undergoing renal replacement therapy or those with end-stage renal disease, as fluid balance and responsiveness may be altered.
- Pregnancy Hemodynamic changes during pregnancy (e.g., increased cardiac output and altered vascular resistance) differ significantly from septic shock.
- Patients with a body mass index (BMI) greater than 40 kg/m² Obesity can affect the accuracy of non-invasive monitoring techniques with poor window.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Menoufia University Hospital
Shibīn al Kawm, Menoufia, 23511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Noha Abdallah Afify, Professor
Anaesthesia, Intensive Care and Pain Management, Faculty of Medicine, Menoufia University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident at Anaesthesia, Intensive Care and Pain Management Department
Study Record Dates
First Submitted
January 30, 2026
First Posted
February 13, 2026
Study Start
May 10, 2025
Primary Completion
May 10, 2026
Study Completion
May 20, 2026
Last Updated
February 13, 2026
Record last verified: 2025-05